Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications

Radiation Oncology

Jan J Wilkens¹  Tatiana Wenzl¹ 

[1] Department of Radiation Oncology, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 Munich, Germany

关键词: radiation therapy;    high LET;    fractionation;    oxygen effect;    hypoxia;    Oxygen enhancement ratio;   

Others  :  1160927
DOI  :  10.1186/1748-717X-6-171

 received in 2011-09-23, accepted in 2011-12-15,  发布年份 2011

【 摘 要 】

Background

The increased resistance of hypoxic cells to ionizing radiation is usually believed to be the primary reason for treatment failure in tumors with oxygen-deficient areas. This oxygen effect can be expressed quantitatively by the oxygen enhancement ratio (OER). Here we investigate theoretically the dependence of the OER on the applied local dose for different types of ionizing irradiation and discuss its importance for clinical applications in radiotherapy for two scenarios: small dose variations during hypoxia-based dose painting and larger dose changes introduced by altered fractionation schemes.

Methods

Using the widespread Alper-Howard-Flanders and standard linear-quadratic (LQ) models, OER calculations are performed for T1 human kidney and V79 Chinese hamster cells for various dose levels and various hypoxic oxygen partial pressures (pO2) between 0.01 and 20 mmHg as present in clinical situations in vivo. Our work comprises the analysis for both low linear energy transfer (LET) treatment with photons or protons and high-LET treatment with heavy ions. A detailed analysis of experimental data from the literature with respect to the dose dependence of the oxygen effect is performed, revealing controversial opinions whether the OER increases, decreases or stays constant with dose.

Results

The behavior of the OER with dose per fraction depends primarily on the ratios of the LQ parameters alpha and beta under hypoxic and aerobic conditions, which themselves depend on LET, pO2 and the cell or tissue type. According to our calculations, the OER variations with dose in vivo for low-LET treatments are moderate, with changes in the OER up to 11% for dose painting (1 or 3 Gy per fraction compared to 2 Gy) and up to 22% in hyper-/hypofractionation (0.5 or 20 Gy per fraction compared to 2 Gy) for oxygen tensions between 0.2 and 20 mmHg typically measured clinically in hypoxic tumors. For extremely hypoxic cells (0.01 mmHg), the dose dependence of the OER becomes more pronounced (up to 36%). For high LET, OER variations up to 4% for the whole range of oxygen tensions between 0.01 and 20 mmHg were found, which were much smaller than for low LET.

Conclusions

The formalism presented in this paper can be used for various tissue and radiation types to estimate OER variations with dose and help to decide in clinical practice whether some dose changes in dose painting or in fractionation can bring more benefit in terms of the OER in the treatment of a specific hypoxic tumor.

【 授权许可】

   
2011 Wenzl and Wilkens; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Höckel M, Schlenger K, Mitze M, Schäffer U, Vaupel P: Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996, 6:3-9.
• [2]Rofstad EK, Sundfør K, Lyng H, Tropé CG: Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 2000, 83:354-359.
• [3]Vaupel P, Mayer A: Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007, 26:225-239.
• [4]Wang JZ, Li XA, Mayr NA: Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data. Br J Radiol 2006, 79:905-911.
• [5]Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, West CM: Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiaother Oncol 2000, 57:53-59.
• [6]Malinen E, Søvik Å, Hristov D, Bruland ØS, Olsen DR: Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006, 51:4903-4921.
• [7]Mönnich D, Troost EG, Kaanders JH, Oyen WJ, Alber M, Thorwarth D: Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps. Phys Med Biol 2011, 56:2045-2057.
• [8]Søvik Å, Malinen E, Olsen DR: Strategies for biologic image-guided dose escalation: a review. Int J Radiat Oncol Biol Phys 2009, 73:650-658.
• [9]Thorwarth D, Alber M: Implementation of hypoxia imaging into treatment planning and delivery. Radiother Oncol 2010, 97:172-175.
• [10]Wenzl T, Wilkens JJ: Modelling of the oxygen enhancement ratio for ion beam radiation therapy. Phys Med Biol 2011, 56:3251-3268.
• [11]Kellerer AM, Rossi HH: A generalized formulation of dual radiation action. Radiat Res 1978, 75:471-488.
• [12]Sachs RK, Hahnfeld P, Brenner DJ: The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 1997, 72:351-374.
• [13]Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M: Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol 2004, 49:4477-4491.
• [14]Paganetti H: Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002, 53:407-421.
• [15]Hall EJ, Giaccia AJ: Radiobiology for the radiologist. 6th edition. Philadelphia: Lippincott Williams and Wilkins; 2006.
• [16]Wouters BG, Brown JM: Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res 1997, 147:541-550.
• [17]Petit SF, Dekker AL, Seigneuric R, Murrer L, van Riel NA, Nordsmark M, Overgaard J, Lambin P, Wouters BG: Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study. Phys Med Biol 2009, 54:2179-2196.
• [18]Alper T, Howard-Flanders P: Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 1956, 178:978-979.
• [19]Carlson DJ, Keall PJ, Loo BW Jr, Chen ZJ, Brown JM: Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys 2011, 79:1188-1195.
• [20]Brenner DJ: The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008, 18:234-239.
• [21]Höckel M, Vaupel P: Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93:266-276.
• [22]Stone HB, Brown JM, Phillips TL, Sutherland RM: Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat Res 1997, 136:422-434.
• [23]Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38:285-289.
• [24]Antipas VP, Stamatakos GS, Uzunoglu NK, Dionysiou DD, Dale RG: A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration. Phys Med Biol 2004, 49:1485-1504.
• [25]Carlson DJ, Stewart RD, Semenenko VA: Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys 2006, 33:3105-3115.
• [26]Raju MR, Amols HI, Bain E, Carpenter SG, Cox RA, Robertson JB: A heavy particle comparative study. Part III. OER and RBE. Br J Radiol 1978, 51:712-719.
• [27]Prise KM, Folkard M, Davieset S, Michael BD: The irradiation of V79 mammalian cells by protons with energies below 2 MeV. II. Measurement of oxygen enhancement ratios and DNA damage. Int J Radiat Biol 1990, 58:261-277.
• [28]Skarsgard LD, Harrison I: Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. Radiat Res 1991, 127:243-247.
• [29]Wilkens JJ, Oelfke U: A phenomenological model for the relative biological effectiveness in therapeutic proton beams. Phys Med Biol 2004, 49:2811-2825.
• [30]Chapman JD, Gillespie CJ, Reuvers AP, Dugle DL: The inactivation of Chinese hamster cells by × rays: the effects of chemical modifiers on single- and double-events. Radiat Res 1975, 64:365-375.
• [31]Watts ME, Hodgkissn RJ, Jones R, Fowler JF: Radiosensitization of Chinese hamster cells by oxygen and misonidazole at low X-ray doses. Int J Radiat Biol 1986, 50:1009-1021.
• [32]Sapora O, Barone F, Belli M, Maggi A, Quintiliani M, Tabocchini MA: Relationship between cell killing, mutation induction and DNA damage in X-irradiated V79 cells; the influence of oxygen und DMSO. Int J Radiat Biol 1991, 60:467-482.
• [33]Sprong D, Janssen HL, Vens C, Begg AC: Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status. Int J Radiat Oncol Biol Phys 2006, 64:562-572.
• [34]Raju MR, Amols HI, Bain E, Carpenter SG, Cox RA, Robertson JB: OER and RBE for negative pion beams of different peak widths. Br J Radiol 1979, 52:494-498.
• [35]Freyer JP, Jarrett K, Carpenter S, Raju MR: Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. Radiat Res 1991, 127:297-307.
• [36]Ma N, Durante M, Lai S, Tinganelli W, Weyrather WK: Cellular response of CHO-K1 cells to X-ray irradiation under different states of oxygenation. In GSI Scientific Report 2010. Edited by Große K. Darmstadt: GSI Helmholtzzentrum für Schwerionenforschung GmbH; 2010:460.
• [37]Hall EJ: The effect of Hypoxia on the repair of sublethal radiation damage in cultured mammalian cells. Radiat Res 1972, 49:405-415.
• [38]Curtis SB: The OER of mixed high- and low-LET radiation. Radiat Res 1976, 65:566-572.
• [39]Tenforde TS, Curtis SB, Crabtree KE, Tenforde SD, Schilling WA, Howard J, Lyman JT: In vivo cell survival and volume response characteristics of rat rhabdomyosarcoma tumors irradiated in the extended peak region of carbon- and neon-ion beams. Radiat Res 1980, 83:42-56.
• [40]Urano M, Goitein M, Verhey L, Mendiondo O, Suit HD, Koehler A: Relative biological effectiveness of a high energy modulated proton beam using a spontaneous murine tumor in vivo. Int J Radiat Oncol Biol Phys 1980, 6:1187-1193.
• [41]Blakely EA, Tobias CA, Yang TC, Smith KC, Lyman JT: Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams. Radiat Res 1979, 80:122-160.
• [42]Guichard M, Lachet B, Malaise EP: Measurement of RBE, OER and recovery of potentially lethal damage of a 645 MeV helium ion beam using EMT6 cells. Radiat Res 1977, 71:413-29.
• [43]Born R: Die Abhängigkeit des Sauerstoffeffekts von der Dosisleistung. Strahlentherapie 1978, 154:650-652.
• [44]Shridhar R, Estabrook W, Yudelev M, Rakowski J, Burmeister J, Wilson GD, Joiner MC: Characteristic 8 keV × rays possess radiobiological properties of higher-LET radiation. Rad Res 2010, 173:290-297.
• [45]Furusawa Y, Fukutsu K, Aoki M, Itsukaichi H, Eguchi-Kasai K, Ohara H, Yatagai F, Kanai T, Ando K: Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated 3He-, 12C- and 20Ne-ion beams. Radiat Res 2000, 154:485-496.
• [46]Curtis SB, Schilling WA, Tenforde TS, Crabtree KE, Tenforde SD, Howard J, Lyman JT: Survival of oxygenated and hypoxic tumor cells in the extended-peak regions of heavy charged-particle beams. Radiat Res 1982, 90:292-309.